OMALIZUMAB
omalizumab 150 mg/mL injection, 1 mL pen device
OMALIZUMAB (14938F)
14938F
Manner of administration:Injection
Restriction
Indication: Severe chronic spontaneous urticaria
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $443.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||